Accessing the full biosynthetic potential encoded in the genomes of fungi is limited by the low 8 expression of many biosynthetic gene clusters (BGCs) under standard culture conditions. In 9 this work, we develop a fungal CRISPR activation (CRISPRa) system for targeted upregulation 10 of biosynthetic genes, which could accelerate the emerging genomics-driven approach to 11 bioactive secondary metabolite discovery. We construct a fungal CRISPR/dLbCas12a-VPR 12 system and demonstrate activation of a fluorescent reporter in Aspergillus nidulans. Then, we 13 target the native nonribosomal peptide synthetase-like (NRPS-like) gene micA in both 14 chromosomal and episomal contexts, achieving increases in production of the compound 15 microperfuranone. Finally, multi-gene CRISPRa leads to the discovery of the mic cluster 16 product as dehydromicroperfuranone. Additionally, we demonstrate the utility of the variant 17 LbCas12a D156R -VPR for CRISPRa at lower culture temperatures. This is the first 18 demonstration of CRISPRa in filamentous fungi, providing a framework for CRISPR-mediated 19 transcriptional activation of fungal BGCs. 20 activation (CRISPRa)-mediated approach for BGC activation in filamentous fungi (Fig. 1a ). In 49 CRISPRa systems, DNase-deactivated RNA-guided CRISPR/dCas ribonucleoprotein 50 complexes linked to activation effectors are targeted to gene regulatory regions to increase 51 gene expression [17][18][19] . Taking advantage of the streamlined CRISPR RNA (crRNA) cloning 52 and multiplexing capabilities, CRISPRa of BGCs has the potential to greatly accelerate fungal 53 genome mining. CRISPRa has already been used to tune the expression of biosynthetic 54 pathways 20,21 , including in ascomycetous yeasts 22,23 . However, to our knowledge, CRISPRa 55
Introduction 21
Fungal genome mining has emerged as a promising strategy for the discovery of novel 22 bioactive secondary metabolites (SMs) 1,2 . Genomic surveys have revealed that fungal species 23 typically harbour 30-100 biosynthetic gene clusters (BGCs) each encoding the biosynthetic 24 pathway required to produce a SM(s) 3 . However, the vast majority of BGCs remain 25 uncharacterised or 'cryptic' as the products they encode are undetectable under standard 26 culture conditions, often because BGCs remain 'silent' or lowly expressed due to tight 27 regulatory control 1,4 . Filamentous fungi, which have yielded a plethora of SMs with 28 pharmaceutical and agricultural applications 5 , thus serve as attractive targets for genome 29 mining of novel molecules. 30
Improved understanding of SM biosynthesis has led to the development of various 31 bioinformatic tools and strategies for the prioritisation of BGCs for genome mining, increasing 32 the chance of discovery of novel molecules or molecules with desired bioactivities 6,7 . Current 33 strategies for activating specific BGCs typically involve promoter exchange of all individual 34 genes in the BGC with strong promoters 8 . If a BGC contains a transcription factor (TF) gene, 35 overexpression via promoter exchange can activate expression of the entire BGC 9 . However, 36 in many cases this strategy requires further TF engineering 10 , or cluster-specific TFs are not 37 identifiable. BGC from fungi that are genetically intractable require expression in a 38 heterologous host 5 . Filamentous fungi are the most compatible heterologous hosts for 39 expression of fungal BGCs, not requiring intron removal or codon optimization 11 . For example, 40
Aspergillus nidulans has been successfully utilised as a heterologous host by several groups 41 [12] [13] [14] , including ours 15, 16 . Whether in the native fungus or in a heterologous host, promoter 42 exchange can be cumbersome due to the need for marker recycling 13 for chromosomal 43 manipulations, or the challenging episomal cloning of multiple and often large biosynthetic 44 genes 15 . 45
To access cryptic SMs more efficiently and improve the viability of pathway-specific genome 46 mining as an approach for drug discovery, new tools for programmable biosynthetic gene 47 expression are necessary. Inspired by pathway-specific TFs, we aimed to develop a CRISPR 48 to deliver sgRNAs from an independent AMA1-pyroA vector, but when co-transformed with 103 the reporter vector and the dSpCas9-VPR expression vector, fluorescence was not observed 104 ( Supplementary Fig. 2c ). demonstrate consistent mCherry reporter activation, which implies the processing of crRNA 115 array from a PgpdA-derived RNAPII-driven transcript by dLbCas12a-VPR. Activation is 116 observed both episomally and chromosomally encoded dLbCas12a-VPR systems 117
( Supplementary Fig. 1 ). c. Activation strength of the CRISPR/dSpCas9-VPR system showed 118 dependency on dSpCas9-VPR expression strategy ( Supplementary Fig. 2 ). In all microscopy 119 images mycelia were observed under brightfield (BF) and mCherry filter after overnight growth 120 on stationary liquid culture at 37 °C. Scale bar 100 µm. 121
Activating micA for increased microperfuranone production 122
As CRISPR/dLbCas12a-VPR demonstrated better versatility in our initial tests, we decided to 123 proceed to the next phase with this system. To test whether CRISPR/dLbCas12a-VPR 124 mediated activation of fungal biosynthetic genes could induce metabolite production, we 125 targeted the native A. nidulans micA (AN3396) gene which encodes a nonribosomal peptide 126 synthetase-like (NRPS-like) enzyme responsible for the biosynthesis of microperfuranone (1) 127 ( Fig. 2a ). The biosynthetic function of micA had been previously decoded by Yeh et al. 31 , 128 following a promoter replacement strategy, after unsuccessful attempts to elicit the 129 biosynthesis of cryptic NRPS-like products by varying A. nidulans culture conditions. 130
Based on available A. nidulans TSS annotation 32,33 , we followed previously devised guidelines 131
for CRISPRa in eukaryotes 34 and targeted a region 119-303 bp upstream of the TSS with a  132 four-crRNA array named MU (micA Upstream TSS) ( Fig. 2b) . To explore the utility of CRISPRa 133
for genes that lack TSS information, which is the case for 59% of A. nidulans BGC genes 134 ( Supplementary Fig. 3a ), we also tested an alternative TSS annotation-blind targeting criteria, 135 taking the gene start codon as reference. Given that most A. nidulans BGC genes have short 136 5′ untranslated region (UTR) ( Supplementary Fig. 3b ), we targeted a window 139-324 bp 137 upstream of the micA start codon with a four-crRNA named MD (micA Downstream TSS), 138 which in this case corresponds to the 5′ UTR of micA. Analysis by liquid chromatography 139 coupled to a diode array detector and mass spectrometer (LC-DAD-MS) showed increases in 140 the production of 1 in media extracts from all CRISPRa transformants when compared to the 141 background levels in the controls (Fig. 2c ). Interestingly, targeting the 5′ UTR of micA with 142 crRNA array MD resulted in significantly higher production than when targeting the micA 143 promoter region with crRNA array MU, with titres of 1 up to 0.6 mg L -1 ( Fig. 2d ). 144
Nevertheless, targeting with MU still led to a ~4.5-fold increase in production with a titre up to 145 0.2 mg L -1 compared to the controls. No significant difference in performance was observed 146 when comparing between chromosomally and episomally expressed dLbCas12a-VPR 147 systems for both crRNA arrays. 148
In order to enable rapid cloning of different crRNAs for further testing, we established a 149 domesticated version of the AMA1-pyroA expression vector, which allowed one-step Type IIS 150 cloning of crRNA arrays using annealed oligonucleotides ( Supplementary Fig. 4 ). We verified 151 the null effect of PgpdA promoter domestication ( Supplementary Fig. 4b ). 152
To examine the effect of each crRNA in micA activation, individual crRNAs from MD and MU 153 arrays were delivered in strains harbouring chromosomally integrated dLbCas12a-VPR ( Fig.  154 2e and Supplementary Fig. 5 ). We observed a minimal increase in the production of 1 when 155 targeting with some MD crRNA, while in most cases the production of 1 was indistinguishable 156 from the no crRNA control. The broad difference between the production of 1 in strains with 157 single crRNAs and the observed with multiple-crRNA array CRISPRa is indicative of a 158 synergistic activation effect ( Fig. 2e ). 159
To test whether the production of 1 could be further increased, we targeted micA with both 160 MD and MU crRNA arrays simultaneously. To this end, we re-cloned the crRNA array MD into 161 an AMA1-pyrG vector to allow co-transformation with the crRNA array MU encoded on an 162 AMA1-pyroA vector. Co-transformation of both MD and MU crRNA arrays for micA activation 163 resulted in further increase in the production of 1 (up to ~0.8 mg L -1 ) ( Supplementary Fig. 6 ). 164
Interestingly, the crRNA array MD alone delivered from the AMA1-pyrG vector resulted in a 165 considerable increase in the titre of 1 compared to when delivered using AMA1-pyroA vector, 166 which might contribute to the dual crRNA array increased production ( Supplementary Fig. 6 ). 167
Finally, to evaluate the broader utility of CRISPRa targeting episomal genes in A. nidulans, we 168 co-transformed additional copies of micA encoded on an AMA1 vector. The transformants 169 harbouring episomal copies of micA with its full-length promoter showed relatively high basal 170 production of 1 even in the absence of CRISPRa (Fig. 2f ). However, we still observed a 171 consistent increase in the titres of 1 when CRISPRa of micA was performed with either MD or 172 MU crRNA arrays, reaching up to over 4 mg L -1 ( Fig. 2f ). We further tested targeting a shorter 173 episomal micA variant with low basal production of 1. When co-transforming with MD, targeting 174 the still-present 5′ UTR, we observed the largest activation fold change with a ~30-fold 175 increase in the production of 1 compared to the control, reaching final titres of ~1.5 mg L -1 176 ( Fig. 2g ). Taken together, these results show that CRISPRa can affect the expression of 177 episomally encoded genes, as the increase in the production of 1 is not explained by the 178 activation of chromosomal micA alone. 179 Numbers assigned to MD crRNAs are indicative of targeting position in respect to micA start 184 codon, with their position in the crRNA array MD also indicated in the scheme. c. DAD (λ=254 185 nm) chromatograms of A. nidulans culture media extracts show increases in the peak 186 identified as 1 in strains with CRISPR-mediated activation of micA (magenta and blue) as 187 compared to the control with no crRNA (grey). Expected mass of 1 is observed as main ion in 188 the peak by MS. d. CRISPR-mediated activation of chromosomal micA. All CRISPRa strains 189 showed a significant increase in the production of 1 compared to their respective dLbCas12a-190 VPR control with no crRNA. Targeting CRISPRa with MD crRNA array (blue) resulted in 191 significantly higher production of 1 compared to targeting with MU crRNA (magenta). There 192 was no significant difference between both dLbCas12a-VPR expression strategies. e. When Supplementary Table 9 . 205
Multi-gene activation uncovered cryptic gene cluster product 206
The gene micA (AN3396) has been proposed to belong to a BGC, which also contains a 207 putative cytochrome P450 (AN3394) and an hypothetical gene (AN3395) 31,35 , henceforth 208 referred to as micB and micC, respectively. However, the final product of the mic cluster has 209 remained uncharacterised. 210
To assess the feasibility of performing simultaneous activation of multiple genes with 211 CRISPR/dLbCas12a-VPR, we aimed to co-activate the proposed mic cluster. We co-212 transformed the four-crRNA array MD targeting micA along with a second crRNA array 213 targeting micB and micC (Fig. 3a ). This new three-crRNA array, named crRNA array P, 214 targeted a window of 209bp in the middle of the short 396 bp bi-directional promoter between 215 the divergently oriented micB and micC genes. We delivered the two crRNA arrays from 216 independent AMA1 episomal vectors in strains harbouring chromosomally integrated 217 dLbCas12a-VPR ( Fig. 3a ). To account for the above-mentioned influence of the crRNA 218 delivery vector selection marker on CRISPRa strength, we tested both dual plasmid delivery 219 combinations with pyrG and pyroA selection markers ( Fig. 3a) . 220 LC-DAD-MS analysis of A. nidulans culture extracts showed that both multiplexed-CRISPRa 221 strains presented a decrease in the precursor microperfuranone (1) and an increase in the 222 production of three new peaks detected by DAD and MS, arbitrarily named peaks I, II and III 223 ( Fig. 3c , Supplementary Fig. 7a-b ). However, the magnitude of the changes in the metabolic 224 profile was dependent on the marker combination used in the delivery of the crRNA arrays. 225
Given that the precursor 1 does not appear to be limiting as it remains present under all 226 configurations, crRNA array P delivery on an AMA1-pyrG vector favoured the production of 227 the peaks I-III compared to when delivered on AMA1-pyroA ( Fig. 3d ). We further tested the 228 best performer crRNA array delivery combination switching to episomally encoded 229 dLbCas12a-VPR and observed an increased production of the peaks I-III relative to the peak 230 from 1 ( Fig. 3d , Supplementary Fig. 7c ). Taken together these results indicate that multiple 231 gene CRISPRa can be used to explore the metabolite products of a cryptic BGC and that the 232 activity can be tuned to favour the final product of the cluster. 233
The observed mass of the ions accumulated in the peaks I-III was m/z 265 [M+H] + , 2 Da less 234 than the molecular mass of 1, suggesting that an oxidation has occurred. Searching the 235 chemical literature for structures related to 1 corresponding to a mass of 264 Da led us to a 236 previously reported metabolite, 3-carboxy-2,4-diphenyl-but-2-enoic anhydride, herein 237 renamed as dehydromicroperfuranone (2) ( Fig. 3b ) first isolated from A. nidulans IFO 6398 as 238 a plant growth promoting compound 36 . We further analysed the CRISPRa strain crude extract 239 by LC-MS/MS and observed that the fragmentation pattern of the 265 m/z ions shared almost 240 all masses with the predicted spectra for 2 by CFM-ID 37 ( Supplementary Table 1 ). 241
To ensure that the production of the peaks I-III is due to CRISPRa co-targeting the micB-C 242 promoter, we further verified the final product of the mic cluster by promoter replacement of 243 micA, micB and micC. When expressing micA and micB from alcohol inducible promoters, the 244 metabolic profile presented the peaks I-III as observed by CRISPRa, although the metabolites 245 were produced in higher quantities ( Supplementary Fig. 8a ). The co-expression of micA-C 246 resulted in the same metabolic profile as micA-B ( Supplementary Fig. 8a ). This revealed the 247 function of MicB as a cytochrome P450 monooxygenase responsible for converting a 248 secondary alcohol on 1 to a ketone group, forming a maleic acid anhydride moiety. 249
To corroborate the structure of the compounds, we attempted to purify the peaks I-III. The 250 peaks I-II co-eluted during semi-preparative HPLC purification, while peak III could be isolated 251 as a single peak. Surprisingly, the 1 H-NMR and 13 C-NMR spectra of the peaks I-II mixture and 252 peak III in deuterated chloroform appear to be identical ( Supplementary Table 2 and 253 Supplementary Fig. 9 -12), and both matched the previously reported chemical shifts for 2 36 . 254
When reconstituting the NMR sample in methanol for analysis by LC-DAD-MS, the purified 255 peaks reverted to multiple peaks ( Supplementary Fig. 8c ) and we further observed that the 256 samples also exist as mixtures when analysed by NMR in deuterated methanol 257 ( Supplementary Fig. 13-14) . These results suggest that the compounds in the peaks I-III are 258 interchangeable tautomeric or opened/closed ring forms in acetonitrile or methanol 259 ( Supplementary Fig. 8d ) but existed as a single entity in chloroform during NMR analysis 260 (Supplementary Table 2 ). Taken together, the results from LC-MS/MS and NMR analysis 261 supported that the metabolite product of the mic cluster as 2. 262 Due to increased polarity, 2 was only extractable from the culture medium with acidified ethyl 263 acetate or adsorbent resin ( Supplementary Fig. 8b ) , which might explain why this compound 264 has not been observed in previous studies where ethyl acetate extraction was used for 265 metabolite profiling of A. nidulans 31, 38 . 266 shown in green alongside the target sites of crRNA MD array (blue) and crRNA P array 271 (orange). b. Proposed dehydromicroperfuranone (2) structure and biosynthetic pathway. c.
272
Representative overlaid DAD (λ=254 nm) chromatograms of media extracts from strains with 273 both crRNA arrays MD and P (orange), crRNA array MD (blue) and crRNA array P (black). 274
Multi-gene CRISPRa results in the increase of the peaks I-III whose main ion m/z 265 yielded 275 a fragmentation pattern matching 2 by LC-MS/MS analysis ( Supplementary Table 1 ). d.
276
Production of each peak in multiple activation strains is dependent on CRISPRa component 277 delivery strategy. The different DAD (λ=254 nm) chromatograms represent three biological 278
replicates per delivery strategy ( Supplementary Fig. 7 ). We observe that the production of the 279 peaks I-III is favoured in the marker combination crRNA MD in an AMA1-pyroA vector and 280 crRNA P in an AMA1-pyrG vector. 281
dLbCas12a D156R improves activation at lower temperatures 282
The activity of Cas12a systems is modulated by temperature 39 . This could compromise the 283 applicability of fungal CRISPRa, as the majority of fungi have optimum growth temperatures 284 between 25 °C and 30 °C 40 and the production of some SMs is favoured at lower 285 temperatures 1 . To evaluate CRISPRa performance at lower temperatures, we observed 286 CRISPR/dSpCas9-VPR and CRISPR/dLbCas12a-VPR mediated activation of the PelcA-287 mCherry reporter across multiple temperatures. The fluorescence observed at 30 °C was 288 comparable to the samples grown at 37 °C in both systems, but at 25 °C only observable in 289 CRISPR/dSpCas9-VPR samples although at lower intensity ( Supplementary Fig. 15 ). 290
Due to the restrictions on dLbCas12a-VPR activity at 25 °C a putative temperature tolerant 291 variant was investigated. Taking inspiration from the AsCas12a E174R variant, recently reported 292 to possess increased double stranded DNA cleavage efficiency in vitro at 25 °C 41 , we built an 293
LbCas12a mutant harbouring the homologous mutation D156R identified by aligning the 294 AsCas12a/LbCas12a crystal structures 42,43 ( Supplementary Fig. 16 ). 295
We tested the variant dLbCas12a D156R -VPR targeting chromosomal micA with the crRNA array 296 MD. We observed significant CRISPR/dLbCas12a D156R -VPR mediated activation at 25 °C, a 297 temperature at which CRISPR/dLbCas12a mediated activation was not observed (Fig. 4b ). 298
However, at 37 °C CRISPR/dLbCas12a D156R -VPR achieved lower final production of 1 than 299 the original dLbCas12a-VPR system (Fig. 4b ). We also observed evidence of 300 CRISPR/dLbCas12a D156R -VPR mediated fluorescence activation at 25 °C ( Fig. 4a , 301 Supplementary Fig. 15 ). 302
The presence of protospacer adjacent motif (PAM) near the target is a critical requirement for 303 CRISPR systems, in the case of LbCas12a systems the sequence TTTV 44 . The variant 304 LbCas12a D156R has been reported to exhibit improved recognition of the non-canonical PAM 305
sequence TTCN 45 . We tested a poly-crRNA array targeting TTCN PAM sites in the 5′ UTR of 306 micA, and observed an improved activation mediated by the dLbCas12a D156R variant over the 307 original dLbCas12a system at 37 °C (Fig. 4b) presents observable fluorescence at 25 °C unlike the original system ( Supplementary Fig. 15 ). 317
In all microscopy images mycelia were observed under brightfield (BF) and mCherry filter. Supplementary Table 9 . 328
Discussion

329
In this work, we reported the first application of CRISPRa in an ascomycetous filamentous 330 fungus belonging to the Pezizomycotina taxon, known to harbour diverse BGCs. We first 331 tested different strategies for expressing both CRISPR/dSpCas9-VPR and 332 CRISPR/dLbCas12a-VPR system components in A. nidulans, observing the activation of a 333 fluorescent reporter. We then demonstrated the feasibility of CRISPR/dLbCas12a-VPR 334 mediated activation of A. nidulans native biosynthetic genes to induce SM production. This led 335 to the rediscovery of dehydromicroperfuranone, in which the molecule was associated with 336 the mic cluster for the first time. Additionally, we demonstrated CRISPRa-mediated 337 upregulation of genes in episomal constructs, which could be a valuable tool to activate BGCs 338 from diverse fungi captured on vectors and heterologously expressed in A. nidulans as a 339 chassis 12,15 . 340
The CRISPR/dLbCas12a-VPR system presented advantages in multiplexing capability and 341 supported expression of CRISPRa components in various configurations. Additionally, as 342
Cas12a successfully processed transcripts driven by the RNAPII promoter PgpdA, it allowed us 343 to build an AMA1-derived CRISPRa vector set with common fungal genetic parts, increasing 344 the potential portability of the CRISPRa system across fungal species. We targeted micA with 345 multiple crRNAs to increase the likelihood of achieving strong activation, an approach used in 346 pooled CRISPRa screenings 46 , and observed a synergistic activation effect. Cas12a has been 347 demonstrated to process up to 25 crRNAs from a single transcript in the literature 47 , indicating 348 that CRISPR/dCas12a systems may have the potential to extend multiplexing to target whole 349
BGCs from a single crRNA array in future works. Additionally, next generation activators 48 350 could improve dCas12a-based CRISPRa activation strength. 351
We also explored the viability of selecting crRNA targets in a TSS annotation-blind manner, 352 considering filamentous fungi genomes in public databases often lack 5′ UTR annotations. In 353 the case of micA, targeting a short distance upstream of the gene start codon, despite falling 354 in the 5'UTR, resulted in successful production of microperfuranone. This is surprising, as it 355 contradicts the possible roadblock of transcription effect 22 , and might imply that the binding of Considering the potential limitation of dLbCas12a-VPR in filamentous fungi with low optimal 361 growth temperatures, we built and tested dLbCas12a D156R -VPR. During the preparation of this 362 manuscript, the LbCas12a D156R variant was reported to exhibit increased low-temperature 363 genome editing efficiency in vivo 50 . Here, we demonstrated that the temperature tolerance 364
property is translatable to CRISPRa, allowing activity at limiting temperatures for the original 365 system. 366
In conclusion, we believe this work represents a valuable expansion to the fungal CRISPR 367 toolbox and provides a foundation for the further development of CRISPR-based 368 transcriptional activators as a tool for the discovery of novel fungal SMs. The CRISPRa vector 369 set could also contribute to SM discovery by targeting different combinations of genes and 370 aiding the elucidation of the resulting SM intermediates, interrogating BGC regulation with 371 specific epigenetic effectors as well as interrogation of other related biological functions. 372
Methods
373
Plasmids Construction 374
Main vectors for the Cas12a systems will be deposited in Addgene. All vectors are listed along 375 with their description and the cloning method used in Supplementary Table 4 . Plasmids were 376 generated using one of the following methods: restriction enzyme cloning with PacI, NotI and 377 T4 DNA ligase; Type IIS assembly with BsmbI and annealed oligo cloning; yeast homologous 378 recombination or isothermal assembly with NEBuilder HiFi DNA Assembly Master Mix (NEB). 379
All primers used are listed in Supplementary Table 8 TtrpC consisted in the sequences delimited in the expression cassette from pBARGPE1 29 , 384 (obtained from the Fungal Genetics Stock Centre) or the modified version pBARGPE1-LIC 52 . 385
To clone dSpCas9-VPR it was amplified from pAG414GPD-dCas9-VPR 18 , which was a gift 386 from George Church (Addgene plasmid #63801). dLbCas12a D832A was amplified from a 387 plasmid kindly provided by Christian Pflüger which was constructed from pY027 53 , a gift from 388
Feng Zhang (Addgene plasmid # 84742) , by site-directed mutagenesis. and fused to VPR 389 amplified from pAG414GPD-dCas9-VPR 18 . PelcA was amplified from pYFAC-CH6 15 . The 390 coding sequence of mCherry was amplified from pMP7601 54 which was a gift from Alex 391 Andrianopoulos (University of Melbourne). A. nidulans sequences were PCR amplified from 392
A. nidulans LO8030 gDNA (chromosomal coordinates indicated in Supplementary Table 5) 55 . 393
AfPU3 was amplified from Aspergillus fumigatus 293 gDNA. And adapted version of pGEM-T 394 (Promega) was used to build the Step 1 crRNA and sgRNA cloning vector. The Cas9 sgRNA 395 cloning cassette was synthesised as gBlock and re amplified when fused to AfPU3 (Sequence 396 at Supplementary note 1). PgpdA crRNA cloning cassette was created by annealed oligo cloning 397 (Sequence at Supplementary note 1). BsmbI domesticated one-step-cloning vector pCRI008 398 was built by PCR site directed mutagenesis of PYFAC-pyroA parts ( Supplementary Fig. 4a ). 399 sgRNA and crRNA design and cloning 400
The target sequences of each crRNA or sgRNA are listed in Supplementary Table 6, along  401 with the PAM sequence and relative distance to target gene start codon and TSS 55 . The 402 spacers were also verified to pass the bioinformatic off-target test against A. nidulans FGSCA4 403 genome sequence with EuPaGDT 56 . All crRNA and sgRNA were synthesised as 404 oligonucleotides with overhangs, as listed in Supplementary Table 7 . Oligos were mixed in 405 equal proportion (10nM), annealed on a thermocycler , phosphorylated in the case of crRNA 406 arrays and ligated with T4 DNA ligase in previously BsmbI digested vectors. 407
For some Cas12a crRNA, one-step cloning was possible in the fungal crRNA expression 408 vector pCRI008. For the rest, crRNA were cloned by a 2-vector cloning procedure 409 ( Supplementary Fig. 4c ). In that case, oligos with encoded crRNA were first cloned into the 410 pGEM-T derived vector pCRI007, and the expression cassette further PCR amplified with 411 primers that reconstituted full PgpdA and added homology arms. The amplicon was then cloned 412 to the final YFAC fungal vector with homology-based cloning. 413
For Cas9 sgRNA, the sgRNAs were first cloned into pCRI010, and the PacI NotI flanked 414 expression cassette digested, purified and ligated to a PacI NotI digested pCRI011 reporter 415 vector. 416
A. nidulans strains construction and transformation 417
A. nidulans strains with either dCas9-VPR and dCas12a-VPR chromosomal expression 418 cassettes were created by polyethylene glycol (PEG)-calcium-based transformation as in Lim 419 et al. 57 with a previously linearised vector containing 1kb homology regions to facilitate 420 homologous recombination in A. nidulans 8030 stcJΔ locus. The fragment also contained the 421
Bar marker, and colonies were selected for resistance to glufosinate extracted from Basta as 422 in Li et al. 16 and the event confirmed by diagnostic PCR. Complete genotype of the parental 423 strains is listed in Supplementary Table 4 . 424
For each transformant strain genotype of the protoplasts used and vectors transformed are 425 listed in Supplementary Table 4 , along with the strategy to supplement all auxotrophies. 426
Protoplasts of A. nidulans LO8030, dCas-VPR expressing parental strains were prepared from 427 germlings as in Lim et al. 57 , mixed with a quarter volume PEG 60% to a final concentration of 428 10 8 protoplasts per ml and frozen at -80 °C for later use. AMA1-vectors were transformed into 429
A. nidulans protoplasts modifying Lim et al. 2012 57 in order to minimise the required 430 transformation volume. In a 2 mL microcentrifuge tube, 60 µL of thawed protoplast solution 431 was incubated with 50 µL of STC buffer and 3 µg of each plasmid contained in maximum total 432 volume of 10 µL. After 20 mins of incubation on ice 350 µL of the calcium PEG 60% mix was 433 added and mixed gently by inversion, followed by a 20 min incubation at room temperature. 434
After adding 1 mL of STC buffer the mix was spread on solid glucose minimal media (GMM) 435 stabilised with sorbitol (SMM), that were then incubated for three days at 37 °C to generate 436 transformant colonies. 437
Fluorescence Microscopy 438
Spores from individual colonies were grown overnight in an incubator when 37° C , unless 439 other incubation temperature specified, in small petri dishes containing liquid GMM to obtain 440 mycelia. Samples grown at 30 °C were incubated overnight, while samples at 25 °C were 441 grown for two days in order to harvest comparable mycelial growth. Fluorescence images 442 were captured on the epifluorescence inverted microscope Eclipse Ti2 (Nikon), using Plan 443
Apo λ 10x /0.45 numerical aperture (NA) objective lens (Nikon) and a Camera DS-Qi2 (Nikon) 444 controlled by NIS Elements Advanced Research (Nikon). Fluorescent microscopy was carried 445 out under a mCherry filter set (562/40 nm excitation, 593 nm dichroic beamsplitter, and 641/75 446 nm emission), using an 800 ms exposure and 9.6x analog gain unless specified otherwise. 447
Brightfield images captured at a 300 ms exposure time with 1x analog gain. Images were 448 recorded using NIS-Elements Advanced Research software package (Nikon). 449
Culture conditions and crude extract preparation 450
For each strain, three separate transformant colonies were picked as replicates for culture 451 analysis and re-streaked individually in a solidified GMM plate to be cultivated for three days 452 at 37 °C to produce spores. Spores were harvested from plates in 0.1% Tween 80 and counted 453 under Neubauer chamber, 2x10 8 spores were inoculated into 250-ml flasks containing 50 ml 454 liquid GMM medium as described previously 15 , additionally adding ampicillin to 50 µg mL -1 and 455 supplementing with riboflavin, uracil uridine, pyridoxine as indicated in Supplementary Table  456 4. Cultures were grown for 2.5 days with shaking set at 200 rpm and 37 °C, unless other 457 Masshunter Workstation Qualitative Analysis (Agilent). To quantify microperfuranone (1) 477 samples were compared to a calibration curve. To this end, a standard of 1 was prepared by 478 weighing approximately 14 mg of purified 1 and diluting in methanol. This procedure was 479 repeated independently 3 times ( Supplementary Fig. 18a ), and a representative regression fit 480 to zero was used to quantify 1 ( Supplementary Fig. 18b ). The coefficient was used to 481 extrapolate the concentrations in the crude extract to the culture media concentrations. 482
For the calculated additive of single crRNA mediated production of 1 in Fig. 2e , the negative 483 control mean was added to the summation of the difference between the mean of each 484 individual crRNA production and the negative control mean, for the four crRNAs tested. 485 
LC-MS/MS analysis 486
Compound isolation and NMR structural characterization 494
For the microperfuranone (1) standard purification, 2 L of 2-days culture media from strain 52 495 ( Supplementary Table 4 ), after induction, was extracted with a mix of ethyl acetate, methanol 496 and acetic acid (89.5:10:0.5). The crude extract was dried in vacuo, resuspended in methanol 497 and loaded onto a Sephadex LH-20 (GE Healthcare) column for fractionation. Fractions 498 containing the target compound were combined and further purified by semi-prep HPLC with 499 a C18 column (Grace, 5 µm, 10 × 250 mm) (isocratic, 40% acetonitrile-water, 4.3mL min -1 ). 500
For purification of dehydromicroperfuranone (2) peaks 4 L of 2-days culture media from strain 501 54 ( Supplementary Table 4 ), after induction, was loaded onto a customized Diaion HP-20 502 (Sigma) column pre-equilibrated with water. The column was then flushed with 2 column-503 volume of water and eluted with methanol. The eluent was dried in vacuo. The crude extract 504 was resuspended with methanol and fractionated using the Sephadex LH-20 column. 505
Fractions containing the target peaks were combined and further purified by Semiprep HPLC 506 with a C18 Preparative Cartridge (Agilent, 5 µm, 21.2 x 150 mm). A gradient method (55% 507 acetonitrile-water to 85% acetonitrile-water in 12 mins, 10 mL min -1 ) was applied for the 508 separation of peak III with peaks I-III. 509
For structural characterisation of 1 and 2, nuclear magnetic resonance (NMR) spectra were 510 collected on Bruker Avance IIIHD 500/600MHz NMR spectrometers, with either CDCl3-d or 511
MeOD-d4 as solvents. NMR data in CDCl3 was in good agreement with the published data 512 (Supplementary Table 2 ; Supplementary Table 3 ) 513
Computational analysis of A. nidulans features 514
The genome assembly and corresponding gene annotations for A. nidulans FGSC A4 were 515 obtained from FungiDB (denoted version 46) 33 Coordinates of predicted BGCs were obtained 516 from the A. nidulans portal on the Joint Genome Institute's MycoCosm resource 58 . The 517 genome was parsed for gene features using Python scripts. Genes falling within cluster 518 boundaries were grouped, forming an additional dataset to facilitate comparison between the 519 whole genome and BGC genes. 520
Lengths of 5′ UTRs were determined for all genes and BGC genes, based on features when 521 available, filtering the genes with 5′ UTRs equal zero. Histograms for each dataset were 522 plotted using the Matplotlib library. 523
To determine the frequency of Cas9 and Cas12a PAM sites, upstream regions for all genes 524 were isolated by taking up to 400 bp upstream of the start codon. When intergenic distance 525 was less than 400 bp, the distance between the start codon and the end of the previous gene 526 was used. Frequencies of the different PAM sites were obtained through regular expression 527 searches of the PAM sequences considering both strands. Histograms for each dataset were 528 plotted as mentioned above. 529
Statistical analysis 530
Statistical analysis was done using GraphPad Prism 8.3.0. All data were analysed with three 531 biological replicates and Two-sided Welch's T-test with Holm-Šídák multiplicity correction per 532 figure, using an alpha of 0.05. All Welch's T-test P-values calculated for each experiment along 533 the details for the multiplicity adjustment are found in Supplementary Table 9 . The spores for each sample were collected from three individual colonies and grown overnight 706 in liquid stationary culture at 37 °C. Samples with similar mycelial growth were observed under 707 mCherry filter and brightfield (BF). Scale bar 100 µm. 708 Supplementary Fig. 2 Supplementary Table 9 . c. The simplified one-vector cloning strategy with 750 the BsmbI-domesticated pCRI008 versus the original two-vector cloning strategy. In the two-751 vector strategy, a shorter PgpdA lacking BsmbI site was cloned into a pGEM-T backbone to 752 create a vector (pCRI007) for type IIS restriction enzyme cloning. This crRNA cassette would 753 be later be amplified by primers that would reconstitute the full PgpdA sequence when 754 incorporated into a fungal vector by homology-based cloning. Table 2 , Supplementary Fig. 9 and 10) , was dried and reconstituted 816 in methanol for the LC-DAD-MS analysis. LC-DAD-MS of co-purified peaks I-II shared the 817 same profile. 1 H NMR analysis of the reconstituted sample in methanol-d also showed that the 818 compounds existed as mixed forms ( Supplementary Fig. 13 and 14 ) . d. Possible 819 interconvertible forms of dehydromicroperfuranone based on possible tautomerisation and cis-820 trans isomerisation of maleic acid to fumaric acid. Note: m/z 283 was occasionally observed 821 to coexist with m/z 265 for the peaks I-IV suggesting that some of the m/z 265 ions detected 822 could be [M+H-H2O] + . However, it is difficult to determine which peaks is in which form as they 823 appear as a single peak in chloroform-d during NMR analysis and converted back to multiple 824 peaks during LC-DAD-MS. 825 826 827 828
Supplementary Fig. 9 at 37 °C is similar to that observed at 30 °C but lower at 25 °C in mycelia at a stage of 846 equivalent growth to that observed in the other temperature conditions. Fluorescence at 25 °C 847 was still distinguishable from the no sgRNA control. b. CRISPR/dLbCas12a-mediated 848 activation was observed for mycelia grown at 37 °C and 30 °C but not observed at 25 °C. The 849 variant dLbCas12a D156R -VPR presents observable fluorescence signal at 25 °C unlike the 850 original system. In all cases, the spores for each sample were collected from three individual 851 colonies and grown in liquid stationary culture overnight in the case of 37 °C, and 30 °C and 852 two days for the samples at 25°C. The photos represent the mCherry channel and bright-field 853 (BF). Scale bar 100 µm. Supplementary Table 2 . 1 H and 13 C NMR data for dehydromicroperfuranone (2) purified as 890 peaks I-II and peak III showing identical chemical shifts in chloroform-d ( Supplementary Fig.  891 9-12). a: overlapping peaks, or tentatively assigned based on prediction. The previously 892
reported NMR chemical shifts for 2 5 are shown in the 897 Supplementary Table 3 . 1 H and 13 C NMR data for microperfuranone (1) in chloroform-d 898 (supplementary Fig. 18-19 ). a: overlapping peaks, or tentatively assigned based on prediction. 899
The previously reported NMR chemical shifts for 1 6,7 are shown in the 
